Assort Health Raises $120 Mn Series C at $1.2 Bn Valuation to Expand Patient Access AI Platform
Advertisement
The latest investment increases Assort Health's total funding to more than $222 million.
Assort Health has raised $120 million in a Series C funding round led by Menlo Ventures, bringing the company's valuation to $1.2 billion as it accelerates the deployment of AI-powered patient access agents across healthcare organizations.
The latest investment increases Assort Health's total funding to more than $222 million. The company said the capital will support its expansion from large provider groups into enterprise health systems and academic medical centers, following significant growth in demand for healthcare automation tools.
Assort's platform is designed to streamline patient access operations by connecting scheduling, intake, insurance eligibility verification, medication refills, and payments through a unified AI-driven workflow. The company positions the platform as an alternative to standalone voice bots by maintaining a continuous patient record across multiple interactions and care settings.
At the core of the platform is Synapse, Assort's proprietary AI model trained on 190 million patient voice interactions, 62,000 care protocols, and 1.6 million decision pathways. The model is built to support specialty care workflows, including orthopedics, neurology, and dermatology, where scheduling and patient routing often require complex clinical and operational decision-making.
The platform operates through four key modules. Concierge manages inbound patient communications, scheduling, and clinical triage. Activate conducts proactive outreach to address referrals, appointment gaps, and outstanding balances. Orchestrate handles administrative workflows and documentation while integrating data into electronic health record systems. Empower provides operational insights and AI tools for healthcare staff.
According to the company, a major differentiator is its Patient Journey Memory layer, which maintains patient context across calls, texts, intake forms, and other interactions. This allows the platform to reference historical insurance information, clinical alerts, and patient preferences without requiring individuals to repeatedly provide the same details.
The funding announcement comes after Assort reported 20x revenue growth over the last 15 months. The company has also expanded its customer base beyond multi-site provider practices into larger health systems.
Among its recent deployments is John Muir Health, where Assort's AI agents are being integrated with existing Epic and Athenahealth infrastructure. The company claims these implementations have increased administrative labor capacity by 115% while contributing to a 5% increase in net appointment volume.
As part of the funding round, Menlo Ventures Partner JP Sanday will join Assort Health's Board of Directors.
Stay tuned for more such updates on Digital Health News
